Section Edited by Ignacio Melero, MD, PhD and Alexandra Snyder Charen, MD
Consisting of predictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studies, clinical trial analyses and identification of novel immune biomarkers. Manuscripts will be prioritized for peer review and publication on the basis of innovation/novelty of the biomarker-oriented research, adequate validation, clinical relevance and technological novelty.
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, Kamil J Cygan, Darius Scott, Se Jeong, Lauren Boucher, Namita T Gupta, Suraj Gupta, Christina Adler, Max S Topp, Rajat Bannerji, Johannes Duell, Ranjana H Advani, Dina M FlinkSee the full list of authors
21 March 2024
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapyHesong Zou, Wei Liu, Xiaojuan Wang, Yi Wang, Chunyang Wang, Chen Qiu, Huimin Liu, Dandan Shan, Ting Xie, Wenyang Huang, Weiwei Sui, Shuhua Yi, Gang An, Yan Xu, Tonghui MaSee the full list of authors
4 March 2024
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancerRyota Shibaki, Daichi Fujimoto, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Junya Fukuoka, Yuki Sato, Takashi Kijima, Hirotaka Matsumoto, Toshihide Yokoyama, Satoru Miura, Akito Hata, Motohiro Tamiya, Yoshihiko Taniguchi, Jun SugisakaSee the full list of authors
15 February 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer typesJeanne Shen, Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W Dulken, Stephanie Bogdan, Maggie Huang, George A Fisher, Sehhoon Park, Se-Hoon Lee, Jun-Eul Hwang, Jin-Haeng Chung, Leeseul Kim, Heon SongSee the full list of authors
14 February 2024
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinomaJihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
14 February 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, Arvind Ravi, Charlene Mantia, Bradley A McGregor, Jacob E Berchuck, Ilana Epstein, Petra Budde, Behnaz Ahangarian Abhari, Elena Rupieper, Jana Gajewski, Ann-Sophie Schubert, Annika L Kilian, Manuel BräutigamSee the full list of authors
2 February 2024
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiativeRiziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, Vittorio Simeon, Monica Rosaria Maiello, Daniela Frezzetti, Paolo Chiodini, Nicola Normanno
2 February 2024
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancerMengting Gao, Xueying Wu, Xi Jiao, Ying Hu, Yanni Wang, Na Zhuo, Fengxiao Dong, Yujiao Wang, Fengyuan Wang, Yanshuo Cao, Chang Liu, Jian Li, Lin Shen, Henghui Zhang, Zhihao Lu
1 February 2024
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PETJohanna E E Pouw, Sayed M S Hashemi, Marc C Huisman, Jessica E Wijngaarden, Maarten Slebe, Daniela E Oprea-Lager, Gerben J C Zwezerijnen, Danielle Vugts, Ezgi B Ulas, Tanja D de Gruijl, Teodora Radonic, Suresh Senan, C Willemien Menke-van der Houven van Oordt, Idris Bahce
1 February 2024
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumabMara Serena Serafini, Stefano Cavalieri, Lisa Licitra, Federico Pistore, Deborah Lenoci, Silvana Canevari, Mario Airoldi, Maria Cossu Rocca, Primoz Strojan, Cvetka Grasic Kuhar, Marco Merlano, Federica Perrone, Andrea Vingiani, Nerina Denaro, Francesco PerriSee the full list of authors
30 January 2024